FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.70
−4.94%Forward multiples
Based on analyst estimates
- P/E forward
- 18.70x
- P/E 2026E
- 21.72x
- P/E 2027E
- 17.16x
- P/E 2028E
- 13.70x
- P/S forward
- 0.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.21x
- Price / sales
- 0.63x
- Price / cash flow
- 9.23x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 0.98x
- EV / EBITDA
- 32.42x
- EV / EBIT
- 239.29x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026